Results 191 to 200 of about 53,318 (258)

Comparing the Efficacy and Safety of Different DOACs (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) for Stroke Prevention in Atrial Fibrillation [PDF]

Dinesh Balamurugan, Collins Gilbert, Michael A�mann, Harsh Bansal   +3 more
openalex   +1 more source

Rivaroxaban use during vitamin K₁ therapy for rodenticide poisoning. [PDF]

Res Pract Thromb Haemost
Escal J, Drague A, Poenou G, Noyel P, Bertoletti L, Tardy B, Delavenne X.   +6 more
europepmc   +1 more source

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

, 2015
Sameer Bansilal, Zachary T. Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, Keith A.A. Fox   +15 more
openalex   +1 more source

First use of andexanet alfa in the management of massive delayed hemothorax. [PDF]

Turk J Emerg Med
Kozlowski M, Antkiewicz J, Choroszewska A, Czolpinski K, Niemynski P.   +4 more
europepmc   +1 more source

Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study. [PDF]

Cancer Immunol Immunother
Zhang H, Li J, Yuan G, Huang S, Li X.
europepmc   +1 more source

Safety and Efficacy of Rivaroxaban Versus Warfarin in Cerebral Venous Thrombosis: A Comprehensive Meta-Analysis. [PDF]

Neurol Int
Ranjan R, Ken-Dror G.
europepmc   +1 more source

Comparison of Acetylsalicylic Acid with Rivaroxaban or Alternative Anticoagulants for Thromboprophylaxis in Elective Total Hip Arthroplasty: A Retrospective Cohort Study.

Russell P. Norman, Jason Kielly, Kwadwo Osei Bonsu, Rufaro S Chitsike, Stephanie Young   +4 more
openalex   +2 more sources

"DOACs for Left Ventricular Thrombus: Persistent Equipoise Despite New Observational and Randomized Data": comment. [PDF]

Res Pract Thromb Haemost
Dziewierz A, Jarosz P, Rakowski T.
europepmc   +1 more source

Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis [PDF]

Christiane Engelbertz, Ursula Marschall, Jannik Feld, Lena Makowski, Stefan A. Lange, Eva Freisinger, Joachim Gerß, Günter Breithardt, Andreas Faldum, Holger Reinecke, Jeanette Köppe   +10 more
openalex   +1 more source

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation [PDF]

, 2017
Colleen A. McHorney, Veronica Ashton, François Laliberté, Guillaume Germain, Willy Wynant, Concetta Crivera, Jeffrey Schein, Patrick Lefèbvre, Eric D. Peterson   +8 more
openalex   +1 more source